Pharmacokinetic Genes Do Not Influence Response or Tolerance to Citalopram in the STAR*D Sample

Karin Herrlin, Norio Yasui-Furukori, Gunnel Tybring, Jolanta Widén, Lars L. Gustafsson, Leif Bertilsson, Metabolism of citalopram enantiomers in CYP2C19/CYP2D6 phenotyped panels of healthy Swedes British Journal of Clinical Pharmacology. ,vol. 56, pp. 415- 421 ,(2003) , 10.1046/J.1365-2125.2003.01874.X

Martin Hersberger, Jacqueline Marti-Jaun, Katharina Rentsch, Edgar Hänseler, Rapid Detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 Alleles by Tetra-Primer PCR and of the CYP2D6*5 Allele by Multiplex Long PCR Clinical Chemistry. ,vol. 46, pp. 1072- 1077 ,(2000) , 10.1093/CLINCHEM/46.8.1072

A.John Rush, Madhukar H Trivedi, Hicham M Ibrahim, Thomas J Carmody, Bruce Arnow, Daniel N Klein, John C Markowitz, Philip T Ninan, Susan Kornstein, Rachel Manber, Michael E Thase, James H Kocsis, Martin B Keller, The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry. ,vol. 54, pp. 573- 583 ,(2003) , 10.1016/S0006-3223(02)01866-8

Kim Brøsen, Claudio A Naranjo, Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram. European Neuropsychopharmacology. ,vol. 11, pp. 275- 283 ,(2001) , 10.1016/S0924-977X(01)00101-8

David B. Goldstein, Pharmacogenetics in the Laboratory and the Clinic New England Journal of Medicine. ,vol. 348, pp. 553- 556 ,(2003) , 10.1056/NEJME020173

Cristina Rodríguez-Antona, Jane G. Sayi, Lars L. Gustafsson, Leif Bertilsson, Magnus Ingelman-Sundberg, Phenotype-genotype variability in the human CYP3A locus as assessed by the probe drug quinine and analyses of variant CYP3A4 alleles. Biochemical and Biophysical Research Communications. ,vol. 338, pp. 299- 305 ,(2005) , 10.1016/J.BBRC.2005.09.020

J Kirchheiner, K Nickchen, M Bauer, M-L Wong, J Licinio, I Roots, J Brockmöller, Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response Molecular Psychiatry. ,vol. 9, pp. 442- 473 ,(2004) , 10.1038/SJ.MP.4001494

Hua Tang, Tom Quertermous, Beatriz Rodriguez, Sharon L.R. Kardia, Xiaofeng Zhu, Andrew Brown, James S. Pankow, Michael A. Province, Steven C. Hunt, Eric Boerwinkle, Nicholas J. Schork, Neil J. Risch, Genetic Structure, Self-Identified Race/Ethnicity, and Confounding in Case-Control Association Studies American Journal of Human Genetics. ,vol. 76, pp. 268- 275 ,(2005) , 10.1086/427888

Ida Rudberg, Magnhild Hendset, Linda H??rstad Uthus, Espen Molden, Helge Refsum, Heterozygous Mutation in cyp2c19 Significantly Increases the Concentration/dose Ratio of Racemic Citalopram and Escitalopram (s-citalopram) Therapeutic Drug Monitoring. ,vol. 28, pp. 102- 105 ,(2006) , 10.1097/01.FTD.0000189899.23931.76

Melanie M Biggs, Kathy Shores-Wilson, Barry D Lebowitz, Louise Ritz, George Niederehe, for the STAR*D Investigators Group, A.John Rush, Maurizio Fava, Stephen R Wisniewski, Philip W Lavori, Madhukar H Trivedi, Harold A Sackeim, Michael E Thase, Andrew A Nierenberg, Frederic M Quitkin, T.Michael Kashner, David J Kupfer, Jerrold F Rosenbaum, Jonathan Alpert, Jonathan W Stewart, Patrick J McGrath, Sequenced treatment alternatives to relieve depression (STAR * D): rationale and design Controlled Clinical Trials. ,vol. 25, pp. 119- 142 ,(2004) , 10.1016/S0197-2456(03)00112-0